NVS reports $85M of 4Q12 Lovenox sales, up from $34M in 3Q12: http://www.novartis.com/newsroom/media-releases/en/2013/1672350.shtml The $451M of Lovenox sales for the 2012 full year broke down into the four quarters as $176M, $156M, $34M, and $85M. NVS had previously stated that the 3Q12 figure was artificially low due to one-time inventory adjustments.